Panel de la FDA recomienda que no se apruebe Ampligen para SFC

http://www.research1st.com/2012/12/27/fda-panel-votes/
http://translate.google.com.ar/translate?sl=en&tl=es&js=n&prev=_t&hl=es&ie=UTF-8&eotf=1&u=http%3A%2F%2Fwww.research1st.com%2F2012%2F12%2F27%2Ffda-panel-votes%2F&act=url